PDF
File
Beskrivning
| Land | Finland |
|---|---|
| Lista | Spotlight |
| Sektor | Handel & varor |
| Industri | Detaljhandel |
Eevia Health Plc ("Eevia" or "the Company") had a great response during the Vitafoods 2025 tradeshow in Barcelona this week, including new orders from new customers and new prospects. Eevia launched a new, innovative health ingredient, FENO-ARONIA™ 50 Organic, which was warmly received and generated two orders. Eevia also entered a Global Supply agreement for FENO-CHAGA Organic in collaboration with a new partner.
Vitafoods is the premier meeting place for the nutraceutical industry, attracting more than 21,500 professionals from over 160 countries. This year, it was held in Barcelona. Known for its high-quality focus, Vitafoods is a key meeting place in the industry.
At the show, Eevia launched a new unique high-strength, excipient-free health ingredient FENO-ARONIA™ 50 Organic featuring an unmatched concentration of bioactive polyphenols. It is based on Aronia, farmed organically in Finland, and manufactured by Eevia under organic green chemistry principles. The product generated significant interest and two first orders, which is the fastest turnaround from launch to sales the Company has ever seen.
Additionally, Eevia entered a long-term agreement on FENO-CHAGA™ Organic with a new strategic partner.
"Besides the success with FENO-ARONIA and FENO-CHAGA, we also achieved a possible raw-material partnership, which could put us in a very strong position on one key raw material. We were also graced with the support of our Board member, Dr. Diane Clayton, who supported us in many customer meetings and liaised with many scientists that were presenting at various seminars at the show, building our scientific network. This was a good week for Eevia Health," says Stein Ulve, Eevia's CEO.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com or investor@eeviahealth.com
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses global health challenges with bioactive compounds sustainably extracted from renewable plant materials. It focuses on the gut and related health, including kidney and urinary health.
Eevia Health is a manufacturer of 100% organically certified plant extracts. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.
As a pioneering company, Eevia is developing high-value food ingredients, blended solutions, and biomaterials that significantly benefit human health. Eevia Health operates a modern green-chemistry production facility in Finland with a short value chain and environmentally friendly carbon footprint. Eevia listed its shares at the Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.